Lung Disease Clinical Trials

UAB Lung Health Center
Birmingham Alabama 35294

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Novartis Investigative Site
Birmingham Alabama 35205

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Birmingham Alabama 35294

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Birmingham Alabama 35209
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Birmingham Alabama 35233
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham
Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Liposomal amikacin for inhalation and placebo to evaluate Pulmonary Nontuberculous Mycobacterial Lung Disease

205.477.001039 Boehringer Ingelheim Investigational Site
Birmingham Alabama
Updated

Patients are needed to participate in a clinical research study of tiotropium bromide and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

205.477.001050 Boehringer Ingelheim Investigational Site
Birmingham Alabama
Updated

Patients are needed to participate in a clinical research study of tiotropium bromide and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Birmingham Alabama

Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease

GSK Investigational Site
Birmingham, Alabama 35242
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Florence Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Novartis Investigative Site
Gulf Shores Alabama 36547

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Novartis Investigative Site
Huntsville Alabama 35801

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Huntsville Alabama 35801
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Jasper Summit Research LLC
Jasper Alabama 35501

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Pearl Investigative Site
Jasper Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Jasper Alabama 35501

Patients are needed to participate in a clinical research study evaluating Umeclidinium/vilanterol, Fluticasone propionate/salmeterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Novartis Investigative Site
Mobile Alabama 36608

A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Mobile Alabama 36608
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Mobile Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Mobile Alabama 36608

Patients are needed to participate in a clinical research study of Umeclidinium bromide 62.5mcg, Umeclidinium bromide 125mcg and Fluticasone propionate 250mcg/Salmeterol 50mcg to evaluate Pulmonary Disease, Chronic Obstructive

Novartis Investigative Site
Montgomery Alabama 36109

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

205.478.00243 Boehringer Ingelheim Investigational Site
Montgomery Alabama
Updated

A Phase 4 clinical study for patients with Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Montgomery Alabama 36109
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Montgomery/Alabama Alabama 36106
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Ozark Alabama 36360
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Pell City Alabama 35128
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Pisgah Alabama 35765
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Tuscumbia Alabama 35674
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Novartis Investigative Site
Vestavia Alabama 35216

Patients are needed to participate in a clinical research study of QVA149, Long acting b2-agonist and Placebo to evaluate Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Flagstaff Arizona 86001
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

205.478.00260 Boehringer Ingelheim Investigational Site
Glendale Arizona
Updated

A Phase 4 clinical study for patients with Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Glendale Arizona 85306
Updated

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Novartis Investigative Site
Mesa Arizona 85205

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pearl Investigative Site
Mesa Arizona

Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease

Pulmonary Associates P.A.
Phoenix Arizona 85006

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

Pulmonary Associates
Phoenix Arizona 85006
Updated

A clinical research study of Treatment plus Optimal Medical Therapy and Optimal Medical Therapy for the treatment of Pulmonary Emphysema

Phoenix Arizona

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease

Novartis Investigative Site
Phoenix Arizona 85018

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Phoenix Arizona 85006

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive